Dow goes over 30,000 points on vaccine hopes, Biden transition

  • The sign is displayed Monday at the New York Stock Exchange in New York. Stocks are opening broadly higher on Wall Street on Tuesday, as traders were encouraged by news that the transition of power in the U.S. to President-elect Joe Biden will finally begin, and that Biden had selected Janet Yellen, a widely respected former Federal Reserve chair, as treasury secretary.

    The sign is displayed Monday at the New York Stock Exchange in New York. Stocks are opening broadly higher on Wall Street on Tuesday, as traders were encouraged by news that the transition of power in the U.S. to President-elect Joe Biden will finally begin, and that Biden had selected Janet Yellen, a widely respected former Federal Reserve chair, as treasury secretary. Associated Press

 
 
Updated 11/24/2020 3:08 PM

The Dow Jones Industrial Average broke through 30,000 points Tuesday as investors were encouraged by the latest progress on developing coronavirus vaccines and news that the transition of power in the U.S. to President-elect Joe Biden will finally begin.

Traders were also encouraged to see that Biden had selected Janet Yellen, a widely respected former Federal Reserve chair, as treasury secretary.

 

The Dow rose 454 points, or 1.5%, to close at 30,046. The S&P 500 index, which has a far greater impact on 401(k) accounts than the Dow does, rose 1.6%.

Treasury yields rose as investors became more optimistic about the economy.

0 Comments
                                                                                                                                                                                                                       
 
Article Comments ()
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the X in the upper right corner of the comment box. To find our more, read our FAQ.